机译:类风湿关节炎(RA)和非RA风湿性疾病患者并发肺孢子虫肺炎的预后
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan;
Pneumocystis pneumonia; Rheumatoid arthritis; Rheumatic diseases; β-d-glucan; PCR;
机译:类风湿关节炎(RA)和非RA风湿性疾病患者并发肺孢子虫肺炎的预后
机译:多发性研究发现,类风湿关节炎患者中的肺囊虫性肺炎的临床和放射学特征,与甲氨蝶呤肺炎和肺囊肿性肺炎相比,获得性免疫缺陷综合征的临床和放射学特征。
机译:接受生物制剂治疗的类风湿关节炎患者的急性发作性弥漫性间质性肺疾病的临床和放射学特征:多中心研究揭示了日本肺囊虫性肺炎的重要性。
机译:类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
机译:柳氮磺胺吡啶对类风湿关节炎肺炎克氏杆菌的预防作用的临床研究
机译:尽管成功地使用Baricitinib进行了多种疾病改良抗风湿药物治疗但类风湿关节炎并发系统性硬化症并发间质性肺炎和1型糖尿病的风湿性关节炎患者的临床和影像学评估的五十二周结果
机译:结缔组织疾病患者DNA扩增检测肺细胞肺炎:重新评估血管肺炎患者风湿病的临床特征